ARID1A and gastric cancer: While Zhou et al. have reported lower ARID1A protein expression levels in GCs compared to normal gastric tissue, recent studies suggest that complete or partial loss of ARID1A expression is associated with both reduced progression-free survival (PFS) and overall survival (OS) in patients with GC [15,20,22,29,36,37,38,39].